Background: Late relapse with presentation of metastatic disease >5 years after nephrectomy with curative intent is a known behavior of renal cell carcinoma (RCC), but data on outcomes, especially regarding targeted therapies, are limited. In this study, we analyze clinicopathologic features and response to targeted therapy in patients with late-relapse metastatic RCC (mRCC)
Objective. To investigate the efficacy of surgery in the treatment of metastatic renal cell carcinom...
Until recently, the standard treatment for metastatic renal cell carcinoma (RCC) was nonspecific imm...
Objective. To investigate the efficacy of surgery in the treatment of metastatic renal cell carcinom...
BACKGROUND: A subset of primarily localized renal cell carcinoma (RCC) patients will experience dise...
This thesis provides novel insights into the detection, recurrence patterns and management of metast...
AbstractWe report a patient with metastatic clear-cell renal cell carcinoma (mRCC) who presented wit...
Renal cell carcinoma (RCC) is responsible for 4% of all neoplasms in adults and for 80% of all prima...
Renal cell carcinoma (RCC) is a common malignancy. Metastases can be seen both synchronously, at the...
BACKGROUND: Targeted therapies improve survival in metastatic renal cell carcinoma (mRCC). However, ...
Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years ...
Copyright © 2015 A. Magdy et al.This is an open access article distributed under theCreativeCommonsA...
Very few studies have followed patients with renal cell carcinoma for long enough to characterize la...
What's known on the subject? and What does the study add? With recent improvements in the prognosis ...
Objective: To investigate whether time from nephrectomy (Nx) to the diagnosis of metastatic disease ...
Recent phase III studies of targeted agents for metastatic renal cell carcinoma (mRCC) have generate...
Objective. To investigate the efficacy of surgery in the treatment of metastatic renal cell carcinom...
Until recently, the standard treatment for metastatic renal cell carcinoma (RCC) was nonspecific imm...
Objective. To investigate the efficacy of surgery in the treatment of metastatic renal cell carcinom...
BACKGROUND: A subset of primarily localized renal cell carcinoma (RCC) patients will experience dise...
This thesis provides novel insights into the detection, recurrence patterns and management of metast...
AbstractWe report a patient with metastatic clear-cell renal cell carcinoma (mRCC) who presented wit...
Renal cell carcinoma (RCC) is responsible for 4% of all neoplasms in adults and for 80% of all prima...
Renal cell carcinoma (RCC) is a common malignancy. Metastases can be seen both synchronously, at the...
BACKGROUND: Targeted therapies improve survival in metastatic renal cell carcinoma (mRCC). However, ...
Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years ...
Copyright © 2015 A. Magdy et al.This is an open access article distributed under theCreativeCommonsA...
Very few studies have followed patients with renal cell carcinoma for long enough to characterize la...
What's known on the subject? and What does the study add? With recent improvements in the prognosis ...
Objective: To investigate whether time from nephrectomy (Nx) to the diagnosis of metastatic disease ...
Recent phase III studies of targeted agents for metastatic renal cell carcinoma (mRCC) have generate...
Objective. To investigate the efficacy of surgery in the treatment of metastatic renal cell carcinom...
Until recently, the standard treatment for metastatic renal cell carcinoma (RCC) was nonspecific imm...
Objective. To investigate the efficacy of surgery in the treatment of metastatic renal cell carcinom...